Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
Introduction: The event of SARS-CoV-2 serological assessments is very large. The exterior validation of their efficiency is required earlier than use in scientific routine follow.
Aims: Our examine goals at assessing the analytical and scientific efficiency of two ELISA assessments detecting antibodies directed in opposition to the virus nucleocapsid protein: The NovaLisa® SARS-CoV-2 IgG, IgA, and IgM check (NovaTec®) permitting a separate detection of every antibody and the Platelia® SARS-CoV-2 Complete Ab check (Bio-Rad®) detecting complete antibodies (IgM, IgA and IgG).
Strategies: 200 and eight COVID-19 samples from 48 RT-qPCR confirmed sufferers have been used to carry out the sensitivity evaluation. Non-SARS-CoV-2 sera (n = 79) with a possible cross-reaction to SARS-CoV-2 immunoassays have been included within the specificity evaluation. As well as, utilizing ROC curves, tailored cut-off for enchancment of the performances have been proposed. The kinetics of those antibodies was additionally assessed over Eight weeks.
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit
Outcomes: Two weeks after the RT-qPCR constructive detection, the NovaLisa® check reveals a sensitivity and specificity of 94.9% (95%CI: 83.1-98.6%) and 96.2% (95%CI: 89.4-98.7%) for IgG, of 89.7% (95%CI: 76.4-95.9%) and 98.7% (95%CI:93.2-98.8%) for IgA, and of 48.7% (95%CI: 33.9-63.8%) and 98.7% (95%CI:93.2-99.8%) for IgM. With the Platelia® system, the specificity and sensitivity have been 97.4% (95%CI: 92.1-99.7%) and 94.9% (95%CI:87.7-98.0%) for complete antibodies utilizing the tailored cut-offs.
Conclusion: The NovaLisa® and the Platelia® assessments have passable analytical performances. The scientific performances are wonderful for IgG, IgA and complete antibodies particularly if the cut-off is optimized. This text is protected by copyright. All rights reserved
Anti-Mouse LIF Antibody |
103-M263 |
ReliaTech |
100 µg |
EUR 399 |
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Mouse LIF Antibody |
103-PA05S |
ReliaTech |
100 µg |
EUR 126 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Mouse LIF Protein |
E40MOP1672 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2026 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2028 |
EnoGene |
20ug |
EUR 495 |
Recombinant Mouse LIF |
Z200195 |
ABM |
10 µg |
EUR 85 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200197 |
ABM |
100 µg |
EUR 385 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200199 |
ABM |
1.0 mg |
EUR 1200 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200485 |
ABM |
100 µg |
EUR 1500 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
anti- LIF antibody |
FNab09804 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against LIF |
Mouse LIF ELISA Kit |
EML0014 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse LIF ELISA Kit |
EK5250 |
SAB |
96 tests |
EUR 599 |
|
Mouse LIF ELISA Kit |
E28L0650 |
EnoGene |
96T |
EUR 666.67 |
Mouse LIF shRNA Plasmid |
20-abx971321 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Mouse LIF Recombinant Protein |
M30-007 |
ReliaTech |
10 µg |
EUR 99.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Mouse LIF Recombinant Protein |
M30-008 |
ReliaTech |
50 µg |
EUR 246.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Recombinant Mouse LIF Protein |
R01400-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
Recombinant Mouse LIF Protein |
PKSM041100-100ug |
Elabscience Biotech |
100ug |
EUR 739 |
|
Description: Mouse |
Recombinant Mouse LIF Protein |
PKSM041100-20ug |
Elabscience Biotech |
20ug |
EUR 249 |
|
Description: Mouse |
Mouse LIF PicoKine ELISA Kit |
EK0580 |
BosterBio |
96 wells |
EUR 510 |
Description: For quantitative detection of mouse LIF in cell culture supernates, serum and plasma (heparin, EDTA). |
Anti-Human LIF Antibody |
102-PA05S |
ReliaTech |
100 µg |
EUR 126 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Anti-Human LIF Antibody |
101-M553 |
ReliaTech |
100 µg |
EUR 399 |
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Lif ORF Vector (Mouse) (pORF) |
ORF049145 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Lif ORF Vector (Mouse) (pORF) |
ORF049146 |
ABM |
1.0 ug DNA |
EUR 607.2 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-001 |
GenDepot |
1ml |
EUR 406.8 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-005 |
GenDepot |
5x1ml |
EUR 1431.6 |
LIF ELISA Kit (Mouse) (OKBB00760) |
OKBB00760 |
Aviva Systems Biology |
96 Wells |
EUR 606 |
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
LIF ELISA Kit (Mouse) (OKEH04045) |
OKEH04045 |
Aviva Systems Biology |
96 Wells |
EUR 652.8 |
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
LIF, Mouse Recombinant , 10MIU/ml |
L4501-001 |
GenDepot |
1ml |
EUR 1744.8 |
Mouse LIF Recombinant Protein Lyophilized |
IMSLIFRLY5UG |
Innovative research |
each |
EUR 317 |
|
Description: Mouse LIF Recombinant Protein Lyophilized |
Human CellExp? LIF, mouse recombinant |
7268-10 |
Biovision |
each |
EUR 444 |
Mouse LIF protein, C-His tag |
PRP1126-100ug |
Abbkine |
100 μg |
EUR 379 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-1mg |
Abbkine |
1 mg |
EUR 2509 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-20ug |
Abbkine |
20 μg |
EUR 149 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-5ug |
Abbkine |
5 μg |
EUR 59 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102 |
Neuromics |
5 ug |
EUR 522 |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102-B |
Neuromics |
each |
EUR 436.5 |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1, (10ug) |
MC208887 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2, (10ug) |
MC208888 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Recombinant Mouse Lif Protein, No Tag |
E40MOP2217 |
EnoGene |
20ug |
EUR 495 |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 2, (10ug) |
MG223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 1, (10ug) |
MG223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1 |
MR223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2 |
MR223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif sgRNA CRISPR Lentivector set (Mouse) |
K3872501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse) |
4-PAA085Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF) |
LIF, Leukemia inhibitory factor, murine (mouse) |
RC234-18 |
Bio Basic |
5ug |
EUR 125.26 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-1mg |
Abbexa |
1 mg |
EUR 3801.6 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x10g |
Abbexa |
3x10 µg |
EUR 393.6 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x2g |
Abbexa |
3x2 µg |
EUR 276 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
20-abx067761 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-10mg |
Abbexa |
10 mg |
EUR 325 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-25mg |
Abbexa |
25 mg |
EUR 3287.5 |
A digital ELISA to quantitate COVID-19 antibodies in affected person serum
-
Enzyme-linked immunosorbent assays (ELISAs) are used extensively in biotechnology, pharmaceutical, and scientific drugs labs. On the identical time, they look like underrepresented in chemistry and biochemistry curricula, although their sensitivity, selectivity, and ease of use would argue for his or her widespread use.
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
abx060621-50g |
Abbexa |
50 µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07948 |
CHI Scientific |
10µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07949 |
CHI Scientific |
50µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07950 |
CHI Scientific |
1mg |
Ask for price |
H3N2 Influenza-A Virus Brisbane 10/07 |
rAP-5410 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
20-abx260509 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
abx260509-10g |
Abbexa |
10 µg |
EUR 325 |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
abx260509-2g |
Abbexa |
2 µg |
EUR 225 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen |
11-567 |
ProSci |
0.1 mg |
EUR 632.4 |
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2) |
Influenza A Strain A/Brisbane/10/07 (H3N2) Protein |
GWB-T00035 |
GenWay Biotech |
1mg |
Ask for price |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
IFLUABN1007H3N2ALR100UG |
Innovative research |
each |
EUR 738 |
|
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant |
rAP-5428 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag |
E40VAG023 |
EnoGene |
20ug |
EUR 495 |
H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant |
rAP-5423 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag |
E40VAG011 |
EnoGene |
20ug |
EUR 495 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set |
ABPR-ZB267 |
Creative Diagnostics |
5 plates, 15 plates |
Ask for price |
Description: Quantitative determination of Influenza Hemagglutinin |
Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG022 |
EnoGene |
20ug |
EUR 495 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
11-563 |
ProSci |
0.05 mg |
EUR 632.4 |
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
11-564 |
ProSci |
0.05 mg |
EUR 632.4 |
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
Influenza B- Virus Brisbane 60/2008 Recombinant |
rAP-5434 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza B (B/Brisbane/60/2008) HA protein, His Tag |
E40VAG161 |
EnoGene |
20ug |
EUR 495 |
Influenza B (B/Brisbane/60/2008) HA protein, His Tag |
E40VAG163 |
EnoGene |
20ug |
EUR 495 |
Influenza A H1N1 (A/Brisbane/59/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG010 |
EnoGene |
20ug |
EUR 495 |
Influenza B (B/Brisbane/60/2008) HA Protein (HA1 Subunit), His Tag |
E40VAG162 |
EnoGene |
20ug |
EUR 495 |
Influenza B (B/Brisbane/3/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG283 |
EnoGene |
20ug |
EUR 495 |
Rabbit Anti-IBV (Influenza B/Brisbane/60/2008) HA2 Polyclonal Antibody |
CABT-CS796 |
Creative Diagnostics |
100 μg |
EUR 520 |
Description: Rabbit |
Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL) |
0810585CFHI |
Zeptometrix |
1 mL |
EUR 422 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug |
QP12081-10ug |
EnQuireBio |
10ug |
EUR 186 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg |
QP12081-1mg |
EnQuireBio |
1mg |
EUR 2470.8 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug |
QP12081-50ug |
EnQuireBio |
50ug |
EUR 241.2 |
Recombinant (HEK) purified Influenza A nucleoprotein (H1N1-NP/1-486aa) protein (A/Brisbane/59/2007, >95%, His-tag) |
H1NP26-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag) |
HA1B012-R-10 |
Alpha Diagnostics |
10 ug |
EUR 343.2 |
Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag) |
HA1B012-R-100 |
Alpha Diagnostics |
100 ug |
EUR 927.6 |
Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag) |
HA1B013-R-10 |
Alpha Diagnostics |
10 ug |
EUR 343.2 |
Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag) |
HA1B013-R-100 |
Alpha Diagnostics |
100 ug |
EUR 927.6 |
Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate |
NAT41634-100 |
The Native Antigen Company |
0.1 |
EUR 512.85 |
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate |
NAT41634-500 |
The Native Antigen Company |
0.5 |
EUR 2181.53 |
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Brisbane 1007 |
iha-024 |
ProSpec Tany |
10µg |
EUR 60 |
Description: Influenza A Virus H3N2 Brisbane 1007 |
Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate |
NAT41641-100 |
The Native Antigen Company |
0.1 |
EUR 523.06 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate |
NAT41641-500 |
The Native Antigen Company |
0.5 |
EUR 2181.53 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate |
NAT41629-100 |
The Native Antigen Company |
0.1 |
EUR 512.85 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate |
NAT41629-500 |
The Native Antigen Company |
0.5 |
EUR 2181.53 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG |
H3N21-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure |
H3N23-A |
Alpha Diagnostics |
100 ul |
EUR 534 |
Recombinant IAV H3N2 (A/Brisbane/10/2007) Hemagglutinin [His] |
DAG-H10412 |
Creative Diagnostics |
100 µg |
EUR 860 |
|
Description: Recombinant |
IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His] |
DAG2224 |
Creative Diagnostics |
100 µg |
EUR 1095.6 |
IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His] |
DAG2328 |
Creative Diagnostics |
100 µg |
EUR 868.8 |
IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His] |
DAG2282 |
Creative Diagnostics |
100 µg |
EUR 1095.6 |
Rabbit Anti-IAV H3N2 (A/Brisbane/10/2007) M2 Polyclonal Antibody |
CABT-CS799 |
Creative Diagnostics |
100 μg |
EUR 520 |
Description: Rabbit |
IAV H1N1 Hemagglutin (aa 51-301) (A/Brisbane/59/2007) [His] |
DAG2202 |
Creative Diagnostics |
100 µg |
EUR 1095.6 |
IAV H1N1 Hemagglutin (aa 18-530) (A/Brisbane/59/2007) [His] |
DAG2220 |
Creative Diagnostics |
100 µg |
EUR 1095.6 |
Influenza A H3 Antibody |
abx021977-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
Influenza A H3 Antibody |
abx021978-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
Influenza A H3 Antibody |
abx021977-400l |
Abbexa |
400 µl |
Ask for price |
Influenza A H3 Antibody |
abx021977-80l |
Abbexa |
80 µl |
EUR 975 |
Influenza A H3 Antibody |
abx021978-400l |
Abbexa |
400 µl |
Ask for price |
Influenza A H3 Antibody |
abx021978-80l |
Abbexa |
80 µl |
EUR 975 |
Influenza B [B/Florida/02/2006] Viral Lysate |
NAT41648-100 |
The Native Antigen Company |
0.1 |
EUR 523.06 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His] |
DAG1775 |
Creative Diagnostics |
50 ug |
EUR 2017.2 |
IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His] |
DAG2279 |
Creative Diagnostics |
100 µg |
EUR 1095.6 |
IAV H3N2 Hemagglutinin 1 (aa 17-346) (A/Brisbane/299/2011 ) [His] |
DAG2246 |
Creative Diagnostics |
100 µg |
EUR 1095.6 |
Mouse Anti-IAV H3N2 (A/Brisbane/10/2007) HA Monoclonal Antibody, Clone 75E2 |
CABT-CS773 |
Creative Diagnostics |
100 μg |
EUR 645 |
|
Description: Mouse |
Recombinant IAV H1N1 Protein (aa 18-530) (A/Brisbane/59/2007) [His] |
VAng-Lsx0333-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His], recombinant protein from HEK 293 cells. |
Influenza B [B/Massachusetts/2/2012] Viral Lysate |
NAT41653-100 |
The Native Antigen Company |
0.1 |
EUR 523.06 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
-
Research design: The goal was to match a business IgG and IgA ELISA (Euroimmun) with three lateral stream immunoassays (LFI): Hangzhou Alltest Biotech, Wuhan UNscience Biotechnology and Guangzhou Wondfo Biotech. Specificity was calculated with 62 out there serum samples from 2018/19. The examine included 152 sera from sufferers of which 109 have been RT-PCR constructive. Sensitivities for ELISA anti SARS-CoV-2 IgG and IgA have been 81.5 % and 93.1 % and specificities 100 % and 80.6 %, respectively. LFI confirmed variable performances, general outcomes being higher for Guangzhou Wondfo Biotech.
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
-
Conclusions: Industrial serological assessments are helpful for detection of antibodies in sufferers with COVID-19. ELISA introduced higher outcomes than LFI. The outcomes allowed to include essentially the most delicate LFI to the day by day workflow, combining with ELISA. Cautious validation is inspired earlier than scientific laboratories begin utilizing these assessments.